Par Drugs and Chemicals Limited has informed the Exchange about the outcomes of their Board meeting, including the approval of their unaudited financial results for the quarter and nine months ended on December 31, 2023, authorization of signing the approved financial results, approval of drafts of advertisements, and evaluation of the performance of independent directors.